Status:
COMPLETED
A Controlled Pregabalin Trial In Fibromyalgia
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To evaluate the efficacy and safety of pregabalin compared with placebo for the relief of pain associated with fibromyalgia and improvement of function of patients with fibromyalgia
Eligibility Criteria
Inclusion
- Patients must meet the ACR criteria for fibromyalgia (ie, widespread pain present for at least 3 months, and pain in at least 11 of 18 specific tender point sites.
- Patients must have a score of \>40 mm on the Visual Analog Scale
Exclusion
- Patients with any widespread inflammatory musculoskeletal disorders, widespread rheumatic diseases other than fibromyalgia, active infections, or untreated endocrine disorders.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
740 Patients enrolled
Trial Details
Trial ID
NCT00230776
Start Date
October 1 2005
End Date
July 1 2006
Last Update
January 26 2021
Active Locations (89)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Little Rock, Arkansas, United States, 72205
2
Pfizer Investigational Site
Fresno, California, United States, 93710
3
Pfizer Investigational Site
La Jolla, California, United States, 92037
4
Pfizer Investigational Site
Northridge, California, United States, 91325